Shea Butter for Pharmaceutical Buyers
Refined N-RBD, identity and purity data per batch, and the statements your qualification file asks for — with our certification scope stated exactly as it is.
Summary
For excipient use EMI Agro supplies refined N-RBD shea butter with a per-batch Certificate of Analysis covering the purity parameters on that certificate. Specification agreements, origin, TSE/BSE, allergen, GMO and residual-solvent statements, change-control notice and audit access are discussed so a pharmaceutical buyer can qualify EMI under its own programme. EMI is NAFDAC registered and HACCP in progress and does not hold excipient GMP certification. See all buyer types we supply and the complete guide to shea butter.
- Recommended grade
- Refined N-RBD
- Minimum / entry order
- Standard orders start at 20 tonnes. Trial lots start at 5 tonnes. Smaller volumes can still be requested — we review every enquiry against current production.
- Lead time
- Lead time is Ibadan production time plus ocean time to the named port. EMI Agro produces 40 tonnes per week of finished shea butter and can schedule rolling shipments. Exact weeks depend on the quantity on the purchase order.
- Certifications relevant to you
- NAFDAC registered, SON approved, HACCP in progress
- Excipient GMP
- Not held
- Start with
- Request a COA
What matters to pharmaceutical buyers
Identity and purity per batch: free fatty acid, peroxide value and moisture as purity; refractive index, saponification value, iodine value and unsaponifiable matter as identity checks against adulteration. Those parameter pages are linked below. See also signs of adulterated shea butter.
A defined specification, signed: limits, methods, sampling, out-of-spec handling. The supplier's numbers become the buyer's incoming-QC acceptance criteria. "Pharmaceutical grade" is not a label a shea butter supplier can grant itself; it is the outcome of the buyer's qualification — and the supplier's job is to make that qualification possible with data, statements and access.
The statement set: origin, TSE/BSE (plant-derived), allergen, GMO, residual solvents — each dated and signed when EMI issues it. Wording is confirmed on enquiry.
Change control: written notice before any change to process, source region, packaging or specification, with re-qualification time. That commitment is part of the specification discussion, not a footnote.
Supplier qualification: questionnaire, document review, audit access, and honesty about which certifications exist. Traceability depth — finished batch to intake lot to cooperative — and shelf-life or retest data are confirmed in that file.
Recommended product and specifications
The product is refined N-RBD shea butter. Batch free fatty acid and peroxide value are on the COA. Identity parameters — refractive index, saponification value, iodine value, unsaponifiables — belong in an excipient spec as an adulteration guard. Methods are listed in shea butter test methods.
Pharmacopoeia references
Check whether the pharmacopoeia you work to (Ph. Eur., USP-NF, BP, JP) carries a current monograph for shea butter / Butyrospermum parkii butter. Do not assume one exists. Where a monograph exists, agreed parameters can be written into the specification; where none exists, the signed specification agreement is the reference and the buyer's own methods apply. EMI does not claim compliance with Ph. Eur. or any other pharmacopoeia.
Specification tables for your use case
Unrefined Grade A for Cosmetics
Unrefined Grade A shea butter for cosmetics: INCI, 2–20 % inclusion, 4–11 % unsaponifiables and the FFA, PV and colour specs to request.
Refined N-RBD for Cosmetics
Refined N-RBD shea butter for cosmetics: white, odourless, low-FFA butter for colour-critical, fragrance-sensitive skincare.
Refined N-RBD for Pharmaceutical Excipient Use
Refined N-RBD shea butter for pharmaceutical excipient use: purity, residual-solvent statements and TDS — not a finished-drug claim.
Parameters to write into your specification:
- Free fatty acid (FFA)
- Peroxide value (PV)
- Moisture and volatiles
- Refractive index
- Saponification value
- Unsaponifiable matter
MOQ, format, lead time and certifications
- Quality-system status
- NAFDAC registered, SON approved, HACCP in progress
- Excipient GMP
- Not held
- Capacity
- 40 tonnes per week of finished shea butter
Minimum order, pilot-batch quantity, formats, lead time, Incoterms, payment, shelf life or retest period and storage are confirmed on the quote. Drum material, liner and closure details belong on that offer.
Documentation pack per batch
Every batch ships with a Certificate of Analysis. See the COA page. A pharmaceutical buyer typically also files a signed specification agreement, certificate of origin, TSE/BSE, allergen, GMO and residual-solvent statements, an SDS, a completed questionnaire and a change-control commitment. Which of those EMI issues today, and which are available on request, is confirmed before they are promised.
Certification scope, stated honestly
Status today: NAFDAC registered, SON approved, HACCP in progress. EMI does not hold excipient GMP certification under the IPEC-PQG GMP Guide, EXCiPACT or NSF/IPEC/ANSI 363. What that means for the buyer: qualification under the buyer's QMS, with a facility visit by appointment. See quality and certifications explained. EMI supplies the COA, the statements it has agreed and the audit access; the pharmaceutical buyer supplies the qualification — and EMI will not describe its certification scope as anything other than what it is.
Why EMI Agro for pharmaceutical buyers
Single-site manufacturer: intake, pressing, refining and laboratory in one facility — one accountable party for the spec and the statements. Botanical name Vitellaria paradoxa (syn. Butyrospermum parkii); INCI Butyrospermum Parkii (Shea) Butter.
Public data, not promises: Certificate of Analysis, quality, about. Incoming QC process for any buyer: quality control for buyers.
Related pages
Food Manufacturers
Food-use documents and chocolate rules.
Contract Manufacturers
Cosmetic manufacturing specs and change control.
Refined N-RBD shea butter
The grade pharmaceutical buyers specify.
Certificate of Analysis
What the COA looks like.
Test methods
AOCS and ISO methods behind each COA line.
Quality control playbook
Incoming inspection and retain samples.
Quality
Certification scope as issued.
Frequently asked questions
References & standards
- European Pharmacopoeia — monograph search (EDQM) — EDQM (accessed 13 September 2026)
- USP-NF — monograph search — USP (accessed 13 September 2026)
- IPEC-PQG Joint Good Manufacturing Practices Guide for Pharmaceutical Excipients — IPEC (accessed 13 September 2026)
- EXCiPACT certification scheme — EXCiPACT (accessed 13 September 2026)
- NSF/IPEC/ANSI 363 — GMP for Pharmaceutical Excipients — NSF (accessed 13 September 2026)
- EMA — minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products — EMA (accessed 13 September 2026)
Last reviewed September 2026 by EMI Agro Industries QC team.
Manufacturer-direct from Ibadan, Nigeria
Request the COA and the statement pack.
Tell us your specification and your pharmacopoeia; we will send a current Certificate of Analysis for refined N-RBD shea butter with the origin, TSE/BSE, allergen, GMO and residual-solvent statements.
You have just read Shea Butter for Pharmaceutical Buyers. The next step is a real lot from the factory that produces it — EMI Agro, with factory-direct pricing and a batch Certificate of Analysis.
Trusted manufacturer
EMI Agro Industries Limited (RC 9364495) presses the butter in Ibadan — we are not a trading company.
Competitive factory-direct prices
Quoted EXW, FOB or CIF — the buyer chooses. You pay the factory, not a chain of middlemen.
Export-ready supply
We ship to European Union, United States, Canada, United Kingdom and Southeast Asia, China, India, Middle East, Latin America. Load ports: Apapa (Lagos) or Tin Can Island (Lagos).
Documented lots
40 tonnes per week of finished shea butter, a Certificate of Analysis on every batch, NAFDAC registered and SON approved.